The neuromodulation-focused Stanford spinout increased its overall funding to $145m in a round led by Ascension Ventures.

Venture capital firm Ascension Ventures led a $77m funding round on Tuesday for Cala Health, a US-based manufacturer of neuromodulation devices based on Stanford University research.

The round also featured Peak6 Strategic Capital, Innovatus Capital Partners, Dolby Family Ventures and all the company’s existing investors, which include pharmaceutical firms Novartis and Johnson & Johnson, internet technology group Alphabet and chipmaker Qualcomm.

Cala produces wearable devices that regulate nervous system activity to treat conditions like essential tremor by stimulating peripheral nerves.…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Fernando Moncada Rivera

Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
email
Linked in